Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR4A2 | P43354 | 1/20 | 0.52 |
| ▸ | IP6K1 | Q92551 | 1/20 | 0.44 |
| ▸ | IP6K2 | Q9UHH9 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.41 |
| ▸ | HPGD | P15428 | 5/20 | 0.41 |
| ▸ | NPC1 | O15118 | 5/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.41 |
| ▸ | RAB9A | P51151 | 5/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.41 |
| ▸ | TP53 | P04637 | 3/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.41 |
| ▸ | GAA | P10253 | 3/20 | 0.41 |
| ▸ | LMNA | P02545 | 3/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | GLA | P06280 | 1/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.41 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
| ▸ | CASP3 | P42574 | 1/20 | 0.41 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4810694 | 0.72 | ALDH1A1 (0.56) | KDM4EHPGDNPC1ALDH1A1RAB9A | |
| SCHEMBL14196049 | 0.72 | ALDH1A1 (0.56) | KDM4EHPGDNPC1ALDH1A1RAB9A | |
| SCHEMBL7450038 | 0.72 | ALOX15 (0.53) | KDM4EHPGDNPC1ALDH1A1RAB9A | |
| SCHEMBL4808364 | 0.69 | PIN1 (0.48) | NR4A2IP6K1IP6K2NPC1RAB9A | |
| SCHEMBL9259362 | 0.69 | ALOX15 (0.55) | KDM4EHPGDNPC1ALDH1A1RAB9A | |
| SCHEMBL9590158 | 0.69 | HDAC2 (0.59) | NR4A2IP6K1IP6K2NPC1GLA | |
| SCHEMBL21219959 | 0.69 | TSHR (0.53) | KDM4EHPGDNPC1ALDH1A1RAB9A | |
| SCHEMBL9259662 | 0.68 | SMN1; SMN2 (0.53) | KDM4EHPGDNPC1ALDH1A1RAB9A | |
| SCHEMBL9259659 | 0.68 | SMN1; SMN2 (0.53) | KDM4EHPGDNPC1ALDH1A1RAB9A | |
| N,N-Dimethylcinnamamide SCHEMBL3743395 | 0.68 | NPC1 (0.65) | IP6K1IP6K2NPC1ALDH1A1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7361665-B2 | Inhibitors of c-Jun N-terminal kinases (JNK) and other protein kinases | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2008-04-22 | — | — | US | disclosed |
| US-20040097531-A1 | Inhibitors of c-Jun N-terminal kinases (JNK) and other protein kinases | VERTEX PHARMACEUTICALS INCORPORATED | 2004-05-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040097531-A1 | Inhibitors of c-Jun N-terminal kinases (JNK) and other protein kinases | LCK, AURKC, CDK5 | NR4A2 3964/4885IP6K1 309/4885IP6K2 327/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.